Background
==========

Depression is a mental disorder with potentially lethal consequences but its pathogenic and therapeutic mechanisms are unknown. Indeed, approximately 3.4% of patients with major depressive disorder (MDD) commit suicide in the United States \[[@b1-medscimonit-22-4577]\]. Early intervention should reduce the suicide rate and decrease treatment time in MDD.

One of the quickest and most effective ways to treat MDD is electroconvulsive therapy (ECT) \[[@b2-medscimonit-22-4577]\]. There is evidence suggesting that patients typically respond to ECT with progressive symptomatic improvement in the first week, and are in complete remission after 3 to 4 weeks \[[@b3-medscimonit-22-4577]--[@b5-medscimonit-22-4577]\]. However, for the several decades during which ECT has been in use, few improvements have been found to enhance its effect and reduce clinical complications. ECT has been shown to be a valid therapeutic tool for treatment of depression but its therapeutic mechanisms are unknown \[[@b3-medscimonit-22-4577]--[@b6-medscimonit-22-4577]\].

Induction of grand mal seizures is the therapeutic basis of ECT and the seizure resulting from ECT is believed to stimulate nerve cells growth and branching especially in the hippocampus \[[@b7-medscimonit-22-4577]--[@b9-medscimonit-22-4577]\]. Results from an animal study found that ECT can produce more robust neuroplastic effects than antidepressant drugs \[[@b10-medscimonit-22-4577]\]. Few studies thus far have focused on the detailed brain structure before and after ECT. Currently, imaging techniques like magnetic resonance imaging (MRI) are used to study MDD \[[@b11-medscimonit-22-4577],[@b12-medscimonit-22-4577]\].

A number of studies have reported changes in grey matter (GM) volume in various brain regions in MDD \[[@b13-medscimonit-22-4577],[@b14-medscimonit-22-4577]\]. In addition to MRI, medications can induce brain volume changes in the hippocampus, amygdala, and temporal lobe \[[@b15-medscimonit-22-4577],[@b16-medscimonit-22-4577]\], and similar results have been observed with ECT \[[@b17-medscimonit-22-4577]\]. The amygdala has been associated with stress and depression. A recent study reported that high doses of electric shock could reduce the number and proportion of amygdala excitatory synaptic to inhibit stress-induced amygdala excitatory change, effectively treating depression \[[@b18-medscimonit-22-4577]\]. An imaging study using region of interest (ROI) analysis reported increased hippocampal volume after ECT in patients with depression \[[@b19-medscimonit-22-4577]\]. Similarly, a recent longitudinal study in 2013 showed that the hippocampal volume increase was reversible after ECT \[[@b20-medscimonit-22-4577]\]. Results in that study indicated that the hippocampal volume returned to baseline, which proved the antidepressant effect of ECT in clinical practice \[[@b20-medscimonit-22-4577]\]. Nevertheless, these results did not screen the whole brain and we still cannot define the importance of the hippocampus and amygdala in ECT.

The imaging techniques of voxel-based morphometry (VBM) provide an opportunity to elucidate the mechanism of ECT. This technique can assess the GM density changes across the entire brain. The superiority of VBM for screening is that it assesses the brain regions equally and comprehensively \[[@b21-medscimonit-22-4577]\]. This imaging technique was used to study schizophrenia, depression, autism, and dyslexia.

Functional MRI (fMRI) has become an important technique for studying advanced activities of the human brain \[[@b22-medscimonit-22-4577],[@b23-medscimonit-22-4577]\]. Performing fMRI in the task-state is complicated, and patient compliance is usually poor, so the results obtained from task-states are difficult to reproduce. As it is free of task, resting-state fMRI reflects the brain's spontaneous baseline functional activity \[[@b24-medscimonit-22-4577]\]. Resting-state fMRI has been used in research on schizophrenia, attention deficit hyperactivity disorder, epilepsy, and depression \[[@b25-medscimonit-22-4577],[@b26-medscimonit-22-4577]\]. Currently, fMRI reports on patients with depression have greatly advanced our understanding of the neuropathology of depression. Functional abnormalities have been found in the anterior cingulate cortex (ACC), dorsolateral prefrontal cortex, hippocampus, striatum, and amygdala \[[@b27-medscimonit-22-4577]--[@b29-medscimonit-22-4577]\] in patients with depression. Yao et al. reported that patients with MDD have extensively distributed abnormal brain activity during resting state \[[@b30-medscimonit-22-4577]\]. Previous studies have also shown that a variety of anti-depressant treatments not only improved the symptoms of depressive patients, but also altered brain function. Exploring the relationship between the efficacy of ECT and the changes in the ECT process may lead to a better understanding of the pathogenesis of MDD and the mechanism of ECT antidepressant activity.

The assessment of regional homogeneity (ReHo), a data-driven method, assumes that a given voxel is temporally similar to its neighbors. It measures the ReHo of the time series of the regional blood oxygen level-dependent (BOLD) signal. Kendall's coefficient of concordance (KCC) is used to measure the similarity of the time series of the voxel with those of its nearest neighbors in a voxel-wise way. Different ReHo of brain activity between depressed patients and controls were explored using second-level statistical analysis on individual KCC maps. The major advantage of ReHo is the ability to detect spontaneous hemodynamic responses of resting-state fMRI \[[@b31-medscimonit-22-4577]\]. Therefore, ReHo reflects the temporal homogeneity of the regional BOLD signal rather than its density. As the BOLD signal of fMRI may reflect neural activity \[[@b32-medscimonit-22-4577]\], the comparison of ReHo value between patients and controls may be used to identify the alterations in local spontaneous brain activity. This method has been applied to various clinical populations to investigate the functional modulations in the resting state \[[@b33-medscimonit-22-4577]--[@b36-medscimonit-22-4577]\]. In addition, ReHo was identified as a neuroimaging marker to investigate neural activity \[[@b36-medscimonit-22-4577]\]. Some authors suggest that the increased ReHo value in some parts of the brain might be responsible for seizure genesis and propagation \[[@b37-medscimonit-22-4577],[@b38-medscimonit-22-4577]\]. Changes of ReHo in the cortex may reflect dysfunction of the corresponding cortical network associated with a specific disorder \[[@b39-medscimonit-22-4577]\].

In the present study, the influence of ECT on the brain structure changes during MDD treatment was longitudinally assessed using VBM analysis after MRI. Resting-state fMRI and ReHo analyses were performed in the same subjects before and after ECT to further assess the functional brain changes after ECT.

Material and Methods
====================

Subjects
--------

Twelve MDD inpatients (8 females and 4 males, aged 34.4±10.1, range 21--55 years) were recruited at the Mental Health Center, the First Affiliated Hospital of Chongqing Medical University, as well as 15 normal controls (10 females and 5 males, aged 36.1±9.4, range 21--55 years). All patients had a unipolar depressive episode and met Diagnostic and Statistical Manual (DSM)-IV criteria for MDD \[[@b40-medscimonit-22-4577]\]. Diagnoses and structured clinical interviews for DSM-IV were based on the consensus of 2 psychiatrists (T.F. and M.J.). The Hamilton Depression (HAMD) Rating Scale was used to assess severe negative emotions and suicidal ideation or behavior \[[@b41-medscimonit-22-4577]\]. All patients underwent a physical examination, including a routine blood test, electroencephalogram, electrocardiogram, and X-ray before ECT. The subjects had not received antipsychotics, antidepressants, mood stabilizers, or ECT for at least 1 month. Patients were all Han Chinese and right-handed. Other general patient information, including sex, age and educational level, was collected.

Exclusion criteria were: 1) contraindication to MRI scanning; 2) neurological disorders; 3) severe somatic disease; 4) substance abuse; 5) pregnancy; 6) lactation; or 7) depression caused by or combined with somatic disease and other psychiatric disorders.

This research was approved by the local Ethics Committee of the Chongqing Medical University, China. All patients and normal controls had given written informed consent before the study.

Electroconvulsive therapy (ECT)
-------------------------------

All 12 patients received 8 sessions of ECT during a 3-week period, 3 times per week (Monday, Wednesday, and Friday) for 2 weeks, and the remaining 2 times (Monday and Friday) for the 3rd week. The patients accepted MRI scanning, fMRI scanning, and HAMD rating on the day before the 1st ECT and the day after the 8th ECT. During the process of ECT, patients did not use any antidepressants and antipsychotics.

ECT was conducted using a Thymatron DGx (Somatics LLC, Lake Bluff, IL) at the Mental Health Center, the First Affiliated Hospital of Chongqing Medical University. The initial dosage selected was normalized based on sex, age, weight, and height, and the stimulus intensity was individually adjusted by the seizure response, effect, and adverse effects during ECT. Anesthesia was induced with sodium thiopental (3.0--5.0 mg/kg) and succinylcholine (0.5--1.0 mg/kg). The d'Elia placement was used for the standard bitemporal placement for bilateral (BL) ECT.

MRI scanning
------------

All MRI scans were conducted using a 3T magnet (Sigma, GE Medical Systems, Waukesha, WI) using a circular polarized birdcage head coil. 3-D T1-weighted anatomical images were acquired using the spoiled gradient recall (SPGR) sequence (repetition time: 8.35 ms; echo time: 3.27 ms; total acquisition time: 7 min; flip angle: 12°; field of view: 24 cm; image matrix: 512×512, slice thickness: 1 mm, voxel size of 0.47×0.47×1 mm^3^, number of slices: 156 sagittal slices).

VBM imaging
-----------

MRI data were analyzed by following the standard steps of optimized VBM in the SPM8 software (*<http://www.fil.ion.ucl.ac.uk/spm/software/spm8/>*). Specifically, all T1 images were corrected for inhomogeneity, registered using a linear affine plus nonlinear transformation, and segmented into GM, white matter (WM), and cerebrospinal fluid (CSF). The resulting GM volume images were modulated by scaling derived from nonlinear transformation matrices. Preprocessed images were then spatially smoothed with a Gaussian kernel (full width at half maximum=8 mm). Smoothed GM images were compared between the healthy control and MDD groups by using independent-samples t-tests (uncorrected, P=0.001).

The optimized VBM toolbox is an extension of the "New Segment Toolbox" in SPM8, using a completely different segmentation approach. The segmentation approach is based on an adaptive Maximum A Posterior (MAP) technique without the need for *a priori* information about tissue probabilities. The MAP estimation is adaptive in the sense that local variations of parameters (e.g., means and variance) are modeled as slowly varying spatial functions \[[@b42-medscimonit-22-4577]\]. Additionally, the segmentation approach uses a Partial Volume Estimation (PVE) with a simplified mixed model of at most 2 tissue types \[[@b43-medscimonit-22-4577]\]. This approach results in an estimation of the amount (or fraction) of each pure tissue type present in every voxel (as each single voxel, given its size, probably contains more than 1 tissue type) and thus provides a more accurate segmentation.

fMRI scanning
-------------

Functional images were acquired using the same 3.0T GE Sigma scanner by using a circular polarized birdcage head coil. After a localization scan, the resting-state functional images were obtained with a gradient-recalled echo-planar imaging sequence. The parameters were as follows: repetition time (TR)=2000 ms, echo time (TE)=30 ms, field of view (FOV)=240×240 mm^2^, data matrix=64×64, flip angle (FA)=90°, 30 slices, slice thickness=5 mm, scanner time=6 min 50 s. Subjects lay supine and were asked to remain motionless, relax with their eyes closed, and without thinking.

fMRI image pre-processing
-------------------------

Image preprocessing was conducted using the Data Processing Assistant for Resting-State fMRI (DPARSF, by YAN Chao-Gan, *<http://www.restfmri.net>*). The first 10 time points were discarded due to the instability of the initial MRI signal and adaptation of subjects to the circumstances, and the remaining 190 time points were used for analysis. As a first step, head motion corrections were performed. All participants should have no more than 1.5 mm maximum displacement in x, y, or z, and 1.5° of angular motion during the whole fMRI scan. Then, after the time-series were corrected, the fMRI images were normalized to the standard SPM8 echoplanar imaging template, resampling to 3×3×3 mm. As a last step, the normalized fMRI images were band-pass filtered (0.01\<f\<0.08 Hz) to reduce the low-frequency drift and physiological high-frequency respiratory and cardiac noise.

ReHo analysis
-------------

ReHo analysis was performed for each subject by calculating Kendall's coefficient concordance (KCC) of time series of a given voxel with its nearest 26 neighboring voxels. The formula for calculating the KCC value was:
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where W is the KCC of a given voxel, ranging from 0 to 1; Ri is the sum rank of the i^th^ time point; *R̄* is the mean of the Ri's; n is the number of ranks; K is the number of time series within a measured cluster (K=27, 1 given voxel plus the number of its neighbors). The ReHo maps were then smoothed with a Gaussian kernel of 4 mm full-width at half-maximum.

Statistics
----------

Statistical analyses were carried out using SPSS 18.0 (SPSS Inc., Chicago, IL). Demographic data and HAMD scores were compared using the paired t-test. Differences were considered statistically significant if *P*\<0.05.

Results
=======

Baseline characteristics of the subjects
----------------------------------------

Demographic data and HAMD score of patients and controls are shown in [Table 1](#t1-medscimonit-22-4577){ref-type="table"}. There was no significant difference in age and education (*P*\>0.05), but HAMD score was highly significantly different (*P*\<0.001) between the 2 groups. All patients scored 33 or higher (35.9±1.3) on the 24-item HAMD Rating Scale at baseline.

Pre-ECT MRI data
----------------

Compared with normal controls, MRI data of the pre-ECT showed that GM volumes were decreased in the right cingulate gyrus (P=0.001, uncorrected, cluster size=142, MNI coordinates were x=15, y=5, z=43, T=4.26, Z=3.66, [Figure 1](#f1-medscimonit-22-4577){ref-type="fig"}), and no brain regions showed increased GM volume at the same threshold more than 10 clusters (P\<0.001, uncorrected).

Post-ECT MRI data
-----------------

Before false discovery rate (FDR) correction, dozens of brain regions showed increased or decreased GM volume after the 8^th^ ECT. After FDR correction, the most significant brain regions, the bilateral amygdala and hippocampus, showed an increase in GM after the 8^th^ ECT. In addition, the comparison between the post-ECT8 and pre-ECT imaging revealed increased GM volume in bilateral amygdala and hippocampus (P\<0.05, FDR corrected, cluster size \>40, [Figure 2](#f2-medscimonit-22-4577){ref-type="fig"}). There was no significant decrease in GM volume between the post-ECT8 and pre-ECT imaging.

Pre-ECT ReHo data
-----------------

ReHo maps of pre-ECT and post-ECT8 are shown in [Figure 3](#f3-medscimonit-22-4577){ref-type="fig"}. Compared with healthy controls, patients with MDD showed increased ReHo in the right caudate nucleus and bilateral inferior parietal lobule, and decreased ReHo in the right superior temporal gyrus, left medial temporal gyrus, left superior temporal gyrus, bilateral parietal cerebellar anterior lobe, left fusiform gyrus, left parahippocampal gyrus, left inferior corpus callosum gyrus, and right pons before treatment ([Table 2](#t2-medscimonit-22-4577){ref-type="table"}).

Post-ECT ReHo data
------------------

As shown in [Table 3](#t3-medscimonit-22-4577){ref-type="table"}, compared with healthy controls, MDD patients after 8 ECT treatments showed increased ReHo in the left superior frontal gyrus, left medial frontal gyrus, right middle frontal gyrus, right inferior frontal gyrus, right caudate nucleus, bilateral angular gyrus, left precuneus, left medial temporal gyrus, and right supramarginal gyrus ([Figure 4A](#f4-medscimonit-22-4577){ref-type="fig"}); and decreased ReHo in the right medial temporal gyrus, right superior temporal gyrus, right cingulate gyrus, and left anterior cerebellar lobe ([Figure 4B](#f4-medscimonit-22-4577){ref-type="fig"}).

Discussion
==========

This study longitudinally assessed the brain structural changes during the process of ECT treatment on MDD patients using an optimized VBM method. Firstly, GM volume was reduced in the right cingulate gyrus of patients with MDD compared with healthy control and pre-ECT groups without correction. Secondly, changes in GM volume were detected in the bilateral amygdala and hippocampus between pre-ECT and post-ECT8 after correction by FDR.

Similar to our results, a recent study showed that the right rostral-anterior cingulate volume was smaller in MDD patients compared with controls \[[@b44-medscimonit-22-4577]\]. Another study found that both anterior cingulate gyri were smaller in women with depression by VBM \[[@b45-medscimonit-22-4577]\]. Several studies have indicated that the cingulate gyrus plays an important role in MDD \[[@b46-medscimonit-22-4577]--[@b48-medscimonit-22-4577]\].

In previous studies it has been noted that there was a significant increase of cells and volumes after several courses of ECT. A recent study using structural MRI revealed that after ECT treatment, the volume of the hippocampus and amygdala were increased in treatment-refractory depression \[[@b49-medscimonit-22-4577]\]. In this study, similar results were obtained in humans. A meta-analysis of related reports from 1985 to 2008 concluded that MDD is associated with amygdala volume, and that amygdala volume of patients who did not receive antidepressant treatment was significantly decreased \[[@b50-medscimonit-22-4577]\]. In this study, results showed that ECT significantly increased GM voxel of the bilateral amygdale in the whole brain. Considering ECT as a kind of fast and effective treatment, the amygdala could be used as an important target in the treatment of MDD. Furthermore, reduced amygdala volume may be due to the reduction of amygdala astrocytes \[[@b51-medscimonit-22-4577]\]. With the scanning of brain regions, distinct changes of voxels focused on hippocampus were observed, as well as the importance of the hippocampus during the treatment of ECT without the disturbance of bias point of researchers. Using VBM, the bilateral amygdala could determine, and the hippocampus was found to play an important role in, the treatment of ECT. This might bring us closer to the core region of action of ECT.

Peng et al. \[[@b52-medscimonit-22-4577]\] reported decreased ReHo value in patients with MDD and the present study is consistent, at least in part, with these findings. Guo et al. \[[@b11-medscimonit-22-4577],[@b53-medscimonit-22-4577]\] and Chen et al. \[[@b54-medscimonit-22-4577]\] investigated the resting-state fMRI in patients with refractory depression and showed a changed ReHo value in the superior temporal gyrus and anterior cerebellum lobe. A previous study reported a tendency toward a decreased temporal lobe volume, which is an important region of the mood-regulating circuit, in patients with depression \[[@b55-medscimonit-22-4577]\]. The superior temporal gyrus was reported to be associated with emotions and feelings of facial stimulation \[[@b56-medscimonit-22-4577]\] and it plays an important role in recognition of facial emotion. Our study revealed a decreased ReHo value in the left fusiform gyrus in MDD patients compared with healthy controls. Fusiform gyrus correlates with facial expression \[[@b57-medscimonit-22-4577]\], an important sign of individual emotion. Yao et al. \[[@b30-medscimonit-22-4577]\] showed an abnormal function of the fusiform gyrus in MDD patients under resting-state. Previous investigations have shown fusiform gyrus dysfunction in a negative emotion regulating model \[[@b58-medscimonit-22-4577]\]. Chan et al. \[[@b59-medscimonit-22-4577]\] and Demaree et al. \[[@b60-medscimonit-22-4577]\] reported that the posterior fusiform gyrus was associated with depression-related emotion information processing. The present study indicated an increase of the ReHo value in the right superior temporal gyrus and fusiform gyrus in MDD patients.

In the present study, 8 courses of ECT led to an increased ReHo value in the left middle temporal gyrus, while the ReHo value of spontaneous electric activity in the left fusiform gyrus remained unchanged. The right superior temporal gyrus showed a decreased ReHo value, suggesting a partial improvement after ECT treatment. The ReHo value in the left parahippocampal gyrus decreased in MDD patients, and the abnormality was not observed after 8 courses of ECT treatment. In a previous study, Suwa et al. \[[@b61-medscimonit-22-4577]\] used positron emission tomography to compare the brain electric activity pre- and post-ECT; they found that the metabolism of the temporal lobe was significantly changed after ECT, suggesting that the temporal lobe might be an important target of ECT.

The present study strongly suggests that the ReHo value in the bilateral parietal cerebellar anterior lobe was decreased in patients with MDD. In recent years, several studies agreed that the cerebellum participates in the cognitive and emotional integrating process, and plays an important role in the identification of feelings and emotion information \[[@b62-medscimonit-22-4577]\]. After using negative stimulation resting-state fMRI pre- and post-treatment by fluoxetine among patients with depression, Fu et al. \[[@b63-medscimonit-22-4577]\] suggested that the improvement in depression symptoms corresponded to the activity of anterior cingulate cortex, ventral striatum, and cerebellum. After 8 courses of ECT, a decreased ReHo value was observed in the left anterior cerebellum lobe, while the ReHo value in the right anterior cerebellum lobe was without abnormal changes. ECT treatment revealed a partial improvement of spontaneous electric activity in the cerebellum, suggesting that the improvement of depressant symptoms from ECT treatment was partially achieved by improving abnormal function activity in the cerebellum.

The results of the present study indicate that ECT can partially reverse the altered brain function and return different brain areas to normal. There are limited comparative investigations on brain function of post-ECT treatment. By using resting-state fMRI among elderly depression patients who were regularly treated with an antidepressant drug and had a clinically significant improvement in symptoms for at least 6 months, Yuan et al. \[[@b64-medscimonit-22-4577]\] showed that abnormal brain activity persisted. Studies have found decreased orientation stimulation in the frontal lobe of elderly patients with depression in clinical recovery \[[@b65-medscimonit-22-4577]\]. This may help explain the consistent abnormal brain activity in spite of clinical improvement in symptoms after ECT treatment. Whether the ECT treatment reverses the abnormal brain activity or creates a new activity level is not clear yet. However, ECT treatment may be involved in the limbic system-cortex-corpus striatum-globus pallidus-thalamus depression nerve pathology loop, in which most abnormal brain regions have been reversed, suggesting further research on the antidepressant mechanism of ECT treatment in the neural network.

This study had a number of limitations. The sample size was quite small, which may limit the representativeness of the patient population. Small ReHo changes (cluster size \<100) might have been missed and additional research using a larger population would be beneficial. Another limitation was the lack of patient follow-up. Future studies may include additional analysis months or years after the final course of ECT. In addition, ROI analyses were lacking, which could have provided more accurate associations between structural and functional changes in both MDD and mechanisms of ECT.

Conclusions
===========

The present study indicated that there were both structural and functional differences between the brains of MDD patients and healthy controls. In addition, after ECT, these structural and functional differences partly disappeared. ECT may have effects through regulating other brain regions to compensate for the original defects.
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![Differences in GM in the right cingulate gyrus between the healthy control and MDD groups. P=0.001, uncorrected, cluster size \>10. T-score bar is shown at right.](medscimonit-22-4577-g001){#f1-medscimonit-22-4577}

![Gray matter was increased post-ECT8 compared with pre-ECT with FDR correction. T-score bar is shown in the middle.](medscimonit-22-4577-g002){#f2-medscimonit-22-4577}

![ReHo maps showing significant differences in brain activity of patients in the MDD group between pre-ECT and post-ECT8. T-score bars are shown in the middle.](medscimonit-22-4577-g003){#f3-medscimonit-22-4577}

![ReHo maps showing significant differences in brain activity between the healthy control and MDD groups post-ECT8. (**A**) Compared with the healthy control group, the MDD group showed increased ReHo in the left superior frontal gyrus, left mediate frontal gyrus, right middle frontal gyrus, right inferior frontal gyrus, right caudate nucleus, bilateral angular gyrus, left precuneus, left medial temporal gyrus, and right supramarginal gyrus. (**B**) Compared with the healthy control group, the MDD group showed decreased ReHo in the right medial temporal gyrus, right superior temporal gyrus, right cingulate gyrus, and left anterior cerebellar lobe. T-score bars are shown below.](medscimonit-22-4577-g004){#f4-medscimonit-22-4577}

###### 

Demographic data of the MDD and healthy control groups.

  No.                         MDD group   Healthy control group   P
  --------------------------- ----------- ----------------------- ---------
  Sex (M/F)                   4/8         5/10                    
  Age (mean (SD))             34.4±10.1   33.7±9.9                0.848
  Education year (mean ±SD)   12.6±2.3    13.8±2.9                0.244
  HAMD                        35.9±1.3    2.2±1.2                 \<0.001

HAMD -- scores of Hamilton Depression Rating Scale.

###### 

Increased ReHo regions and decreased ReHo regions in patients with MDD compared to controls before treatment.

                           Voxel           MNI coordinate (x, y, z)   Z value   Hemicerebrum (left/right)           Brain region      BA partition
  ------------------------ --------------- -------------------------- --------- ----------------------------------- ----------------- --------------
  Increased ReHo regions   27              3, 12, 9                   4.42      Right                               Caudate nucleus   
  30                       60, −39, 21     3.91                       Right     Inferior parietal lobule            40                
  45                       −57, −42, 27    4.49                       Left      Inferior parietal lobule            40                
  27                       54, 0, −12      4.75                       Right     Superior temporal gyrus             38                
  31                       −63, −33, 0     4.27                       Left      Medial temporal gyrus               22                
                                                                      Left      Superior temporal gyrus                               
  31                       −33, −54, −33   4.03                       Left      Parietal cerebellar anterior lobe                     
  Decreased ReHo regions                                                                                            Fusiform gyrus    37
  34                       −12, −45, −30   3.83                       Left      Parietal cerebellar anterior lobe                     
  29                       9, −57, −27     4.32                       Right     Parietal cerebellar anterior lobe                     
  37                       −6, 0, −24      4.66                       Left      Parahippocampal gyrus               34                
                                                                                Inferior corpus callosum gyrus                        
  80                       6, −21, −30     4.95                       Right     Pons                                                  

FEW corrected, P\<0.05. MDD -- major depressive disorder; ReHo -- regional homogeneity.

###### 

Increased ReHo regions and decreased ReHo regions in patients with MDD compared to controls after 8 times of ECT treatment.

                           Voxel          MNI coordinate (x, y, z)   Z value   Hemicerebrum (left/right)   Brain region               BA partition
  ------------------------ -------------- -------------------------- --------- --------------------------- -------------------------- --------------
  Increased ReHo regions   41             42, 42, −3                 4.68      Right                       Middle frontal gyrus       
                                                                               Inferior frontal gyrus                                 
  37                       6, 9, 9        4.03                       Right     Caudate nucleus                                        
  53                       −36, −78, 45   4.43                       Left      Angular gyrus               39                         
                                                                               Precuneus                   19                         
                                                                               Mediate frontal gyrus                                  
  46                       57, −57, 36    4.10                       Right     Supramaginal gyrus          40                         
                                                                               Angular gyrus               39                         
  33                       −18, 27 48     5.14                       Left      Superior frontal gyrus      8                          
                                                                               Mediate frontal gyrus       6                          
  Decreased ReHo Regions   40             −33, −57, −33              3.92      Left                        Cerebellar anterior lobe   
  38                       57, −3, −9     5.29                       Right     Medial temporal gyrus       21                         
                                                                     Right     Superior temporal gyrus                                
  21                       12, 9, 42      5.06                       Right     Cingulate gyrus             32                         

FEW corrected, P\<0.05. MDD -- major depressive disorder; ReHo -- regional homogeneity.
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